Home › Neuroblastoma › Wisconsin
Pag-aaral pangklinika para sa Neuroblastoma sa Wisconsin
6 pag-aaral para sa Neuroblastoma ang naghahanap ng mga kalahok sa mga site sa Wisconsin.
Mga Lungsod sa Wisconsin
Opisyal na teksto ng pag-aaral (English)
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Medical College of Wisconsin, Milwaukee
Nagre-recruitPhase 1/2
Hanggang edad 30 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06541262Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
- Marshfield Medical Center-Marshfield, Marshfield
- Children's Hospital of Wisconsin, Milwaukee
Nagre-recruitPhase 3
Hanggang edad 30 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06172296Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- University of Wisconsin Carbone Cancer Center, Madison
Nagre-recruitPhase 1
7 Months – 21 Years · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT02508038Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
- Midwest Children's Hospital, Milwaukee
Nagre-recruitPhase 1
12 Months – 20 Years · Lahat ng kasarian · Na-update Okt 8, 2026 · NCT02013336Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Saint Vincent Hospital Cancer Center Green Bay, Green Bay
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
- Marshfield Medical Center-Marshfield, Marshfield
- at 1 pa
Nagre-recruitPhase 3
365 Days – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT03126916SPEARHEAD-3 Pediatric Study
- University of Wisconsin Cancer Center, Madison
Nagre-recruitPhase 1/2
Edad 2 hanggang 21 · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05642455Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.